In MGC Pharma’s Doctor access point, doctors can discover information about Medical Cannabis and engage with MGC in order to gain approval to prescribe in Australia. They can also familiarise themselves with MGC’s R&D and clinical pipelines in order to understand the changes that will be coming with the inclusion of Phytocannabinoid medications within the existing treatment spectrum.
Currently in Australia, there are three pathways to prescribe MGC products:
Doctors in Australia wishing to contact MGC Pharma, or find out more about Australia’s prescription process, please contact blaise@mgcpharma.com.au.
